Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam, Mo'iad Tidy, John Osborne, Raymond Coleman, Robert Hancock, Barry W Lawrie, Theresa A
Alazzam, Mo'iad
Tidy, John
Osborne, Raymond
Coleman, Robert
Hancock, Barry W
Lawrie, Theresa A
Advisors
Editors
Other Contributors
Date
2012-12
Date Submitted
Keywords
Other Subjects
Subject Mesh
Drug Resistance, Neoplasm
Female
Gestational Trophoblastic Disease
Humans
Neoplasm Recurrence, Local
Pregnancy
Female
Gestational Trophoblastic Disease
Humans
Neoplasm Recurrence, Local
Pregnancy
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Abstract
Gestational trophoblastic neoplasia (GTN) is a highly curable group of pregnancy-related tumours; however, approximately 25% of GTN tumours will be resistant to, or will relapse after, initial chemotherapy. These resistant and relapsed lesions will require salvage chemotherapy with or without surgery. Various salvage regimens are used worldwide. It is unclear which regimens are the most effective and the least toxic.
Language
en
ISSN
1469-493X
eISSN
ISBN
DOI
10.1002/14651858.CD008891.pub2
PMID
23235667